# TECHNICAL PROVENANCE, SYSTEM INTEGRATION & EVIDENTIARY DEFENSE REPORT
## COLONPATH-AI V3: Multimodal Clinical Decision-Support System for Colorectal Histopathology

**Document Version:** 3.1  
**Date:** September 2026  
**Audience:** Academic Evaluators, Hackathon Jury Members, Clinical Reviewers, Faculty Advisors  
**Purpose:** Provide verifiable evidentiary proof, scientific provenance, and technical attribution for all components in ColonPath-AI V3.

---

## 1. Executive Defense Paradigm: Three-Tier Architectural Attribution

To maintain absolute academic rigor and transparency during evaluation, ColonPath-AI V3 strictly differentiates:
1. **Established Research Components (E1 / E2):** Published architectures and public benchmark datasets developed by the broader computational pathology research community.
2. **ColonPath-AI System Integration:** The pipeline orchestration synchronizing these distinct models into a real-time, end-to-end clinical workflow.
3. **ColonPath-Specific Engineering Contributions (E3):** Original algorithms, feature representations, fusion networks, and validation engines designed specifically for this project.

```
┌─────────────────────────────────────────────────────────────────────────────────────────────────┐
│                           THREE-TIER ARCHITECTURAL ATTRIBUTION MODEL                            │
├───────────────────────────────┬─────────────────────────────────┬───────────────────────────────┤
│ Established Research (E1/E2)  │ ColonPath-AI Integration        │ Project-Specific Contributions│
├───────────────────────────────┼─────────────────────────────────┼───────────────────────────────┤
│ • U-Net (Ronneberger 2015)    │ • Synchronized multi-model pass │ • 16-D Morphology Descriptor  │
│ • HoVer-Net (Graham 2019)     │ • Unified OpenCV mask overlays  │ • MultimodalFusionNet (128D)  │
│ • Phikon-v2 ViT (Filiot 2024) │ • Dynamic FastAPI REST streaming│ • Cross-Evidence Consensus    │
│ • DINOv2 (Oquab 2023)         │ • Recomposition-safe Android flow• EvidenceValidator Gatekeeper│
│ • Temp Scaling (Guo 2017)     │ • Multi-stage error handling    │ • PriorityRegionEngine (2x2)  │
│ • NCT-CRC-HE-100K Dataset     │ • Case lifecycle management     │ • Native Android A4 PDF Engine│
└───────────────────────────────┴─────────────────────────────────┴───────────────────────────────┘
```

---

## 2. Feature-by-Feature Scientific Provenance Table

Every capability in the system is mapped to its exact scientific basis and contribution tier:

| Component / Feature | Scientific / Architectural Basis | Attribution Tier | Primary Citation / Provenance | Implementation Status |
| :--- | :--- | :--- | :--- | :---: |
| **Gland Segmentation** | Encoder-Decoder CNN with skip connections | **E1: Published Architecture** | Ronneberger et al., *MICCAI 2015* ([arXiv:1505.04597](https://arxiv.org/abs/1505.04597)) | ✅ Implemented |
| **Nuclear Instance Segmentation** | Horizontal/Vertical distance maps | **E1: Published Architecture** | Graham et al., *Med Image Anal 2019* ([DOI:10.1016/j.media.2019.101563](https://pubmed.ncbi.nlm.nih.gov/31561183/)) | ✅ Implemented |
| **Nuclear Phenotyping (4 classes)** | CoNSeP multi-class nuclear classification | **E1: Published Benchmark** | Graham et al., *Warwick University 2019* | ✅ Implemented |
| **Pathology Foundation Features** | ViT-L/16 pathology foundation model | **E1: Published Foundation Model** | Filiot et al., *arXiv:2409.09173 (2024)* | ✅ Implemented |
| **Self-Supervised Representation** | DINOv2 self-supervised learning | **E1: Published Foundation Model** | Oquab et al., *arXiv:2304.07193 (2023)* | ✅ Implemented |
| **Confidence Calibration** | Post-hoc temperature scaling ($T=1.25$) | **E1: Published Method** | Guo et al., *ICML 2017* | ✅ Implemented |
| **16-D Morphology Vector** | 8 nuclear + 8 gland geometrical metrics | **E3: Project-Specific Contribution** | ColonPath-AI Morphometry Engine (`cv/morphology/`) | ✅ Implemented |
| **Multimodal Late-Fusion Network** | 1024D visual + 16D morphology $	o$ 128D latent | **E3: Project-Specific Contribution** | ColonPath-AI `MultimodalFusionNet` (`fusion/`) | ✅ Implemented |
| **Cross-Evidence Consensus Engine** | Multi-branch concordance/discordance voting | **E3: Project-Specific Contribution** | ColonPath-AI Consensus Engine (`agreement/`) | ✅ Implemented |
| **EvidenceValidator Gatekeeper** | Programmatic claim tensor verification | **E3: Project-Specific Contribution** | ColonPath-AI Gatekeeper (`agent/validator.py`) | ✅ Implemented |
| **2x2 Spatial Region Triage Queue** | Spatial quadrant attention ranking | **E3: Project-Specific Contribution** | ColonPath-AI Triage Engine (`regions/`) | ✅ Implemented |
| **7-Layer Authentic Streaming Overlays** | Dynamic OpenCV/PIL mask overlay streaming | **E3: Project-Specific Contribution** | ColonPath-AI Visualization API (`visualization/`) | ✅ Implemented |
| **Android Client & Native A4 PDF** | Jetpack Compose + native `PdfDocument` | **E3: Project-Specific Contribution** | ColonPath-AI Android App (`android/`) | ✅ Implemented |
| **Vector DB Reference Retrieval** | Embedding similarity search (Qdrant/Milvus)| **E4: Planned Roadmap** | Vector DB Similarity Search | 🔴 Planned |
| **Dedicated Cancer / Tumor Detector** | Multi-scale tumor extent segmentation | **E4: Planned Roadmap** | Dedicated Tumor Boundary Pipeline | 🔴 Planned |
| **Whole-Slide Gigapixel WSI Tiling** | Multi-resolution pyramid WSI processor | **E4: Planned Roadmap** | Gigapixel Tiling Pipeline | 🔴 Planned |

---

## 3. Authoritative 22-Feature Status Matrix

### ✅ Category 1: Implemented & Defensible in V3 (22 Features)
1. **End-to-End Pathology Analysis Pipeline:** Native Android image upload $	o$ FastAPI $	o$ Real PyTorch inference $	o$ Structured JSON $	o$ SQLite $	o$ UI.
2. **Optical Image Quality QC:** Laplacian blur score, brightness, contrast, and HSV saturation gating.
3. **U-Net Gland Segmentation:** Gland count, area, perimeter, width, height, aspect ratio, and circularity.
4. **HoVer-Net Nuclear Phenotyping:** Instance segmentation of epithelial, inflammatory, spindle-shaped, and miscellaneous nuclei.
5. **16-D Quantitative Morphology Descriptor Vector:** Standardized geometric feature vector feeding late fusion.
6. **Phikon-v2 Visual Representation:** 1024-D self-supervised foundation model embeddings (ViT-L/16 DINOv2).
7. **ColonPath Multimodal FusionNet:** Custom late-fusion neural network combining visual (1024D) and morphology (16D) vectors.
8. **9-Class Tissue Classification:** NCT-CRC-HE-100K 9-class distribution (`ADI`, `BACK`, `DEB`, `LYM`, `MUC`, `MUS`, `NORM`, `STR`, `TUM`).
9. **Temperature Calibration:** Post-hoc calibration ($T=1.25$) mitigating neural overconfidence.
10. **Shannon Entropy & OOD Analysis:** Normalized entropy $H(p)$ and energy out-of-distribution detection.
11. **Multi-Source Consensus Agreement:** Evaluates concordance/discordance across visual, nuclear, and glandular channels.
12. **Evidence-Grounded Explanations:** Deterministically validated claims (`explanation.validated = true`).
13. **2x2 Priority Spatial Regions:** Quad-patch ranking (R_01..R_04) based on localized nuclear packing and gland disruption.
14. **7 Authentic Streaming Visualizations:** `original`, `glands`, `nuclei`, `regions`, `uncertainty`, `top_regions`, `pseudo_3d`.
15. **Android Diagnostic Result Hub:** Material 3 dashboard dynamically bound to real backend DTOs.
16. **Nuclear Morphometry Dashboard:** Subtype counts, mean area, perimeter, circularity, eccentricity, and interpretation.
17. **Gland Architecture Dashboard:** Gland metrics, circularity, aspect ratio, and U-Net clinical findings.
18. **Transparent Comparison Status:** Explicitly indicates single-tile mode without active vector DB (zero fabricated cohort scores).
19. **Dynamic Clinical Decision-Support Report:** Comprehensive clinical summary bound to active case results.
20. **Native Android PDF Generation:** A4 PDF generator utilizing Android's native `PdfDocument` canvas engine.
21. **Case Persistence & Audit Trail:** SQLite database and `case_result.json` recording SHA-256 image hashes and model versions.
22. **Hardened Network & Lifecycle Engineering:** 300s socket timeout, Keep-Alive, and recomposition-safe Compose coroutines.

---

### 🔴 Category 2: Explicitly Planned / NOT in V3

```
🔴 Vector Database / Nearest-Neighbor Reference Case Retrieval
🔴 Real Reference-Case Similarity / Cohort Comparison
🔴 Standalone Dedicated Binary Tumor / Cancer Boundary Detector
🔴 Whole-Slide Image (WSI) Gigapixel Pyramid Tiling
🔴 Slide-Level / Multi-Tile Patient Bag Aggregation
🔴 Multi-Center Prospective Clinical Validation Trials
```

---

### ⚠️ Category 3: Explicit Anti-Claims & Boundaries

```
❌ ColonPath-AI is an AI-assisted research/prototype decision-support system, NOT an autonomous diagnostic system.
❌ No reference similarity score is claimed when Vector DB retrieval is inactive.
❌ No cancer-present/cancer-absent claim is made unless supported by a dedicated validated model/output.
❌ We DO NOT evaluate Whole-Slide Images in the single-tile V3 release.
❌ We DO NOT fabricate metrics not computed by our single-tile pass (e.g. branching index).
❌ We DO NOT use hardcoded mock values (e.g. 1824 nuclei, 37 glands) in production output.
```

---

## 4. State-of-the-Art Comparative Analysis Matrix

| Dimension / Capability | Standard CNN (ResNet / DenseNet) | Pure Foundation ViT (Phikon / UNI / CONCH) | Pure Segmentation Tool (HoVer-Net / QuPath) | COLONPATH-AI V3 (Our Contribution) |
| :--- | :---: | :---: | :---: | :---: |
| **Tissue Classification** | ✅ 9-class logits | ✅ 9-class logits | ❌ None (or rule-based) | ✅ **Calibrated 9-Class ($T=1.25$)** |
| **Cellular Instance Phenotyping** | ❌ No (Black-box) | ❌ No (Black-box) | ✅ Nuclear masks only | ✅ **4-Class Nuclear Phenotyping** |
| **Glandular Architecture Analysis** | ❌ No | ❌ No | ✅ Segmented boundaries | ✅ **Gland Geometry & Lumen Metrics** |
| **Multimodal Feature Fusion** | ❌ Pure visual | ❌ Pure visual | ❌ Morphology only | ✅ **1024D Foundation + 16D Morphology** |
| **Epistemic Uncertainty Estimation** | ❌ Raw softmax | ❌ Raw softmax | ❌ None | ✅ **Shannon Entropy $H(p)$ + OOD Flag** |
| **Cross-Evidence Consensus Voting** | ❌ Single source | ❌ Single source | ❌ None | ✅ **Multi-Branch Concordance Engine** |
| **Anti-Hallucination Claim Validation** | ❌ None | ❌ Free-form LLM risk | ❌ None | ✅ **Deterministic Metric Checker** |
| **Spatial Triage Prioritization** | ❌ Whole patch | ❌ Whole patch | ❌ None | ✅ **2x2 Patch Priority Ranking (R01..R04)** |
| **Histopathology Visual Overlays** | ❌ Grad-CAM heatmap only | ❌ Attention maps only | ✅ Static masks | ✅ **7 Dynamic Streaming Overlays** |
| **Mobile-Edge Native PDF Reporting** | ❌ None | ❌ None | ❌ Desktop export only | ✅ **On-Device Native A4 PDF Generator** |

---

## 5. Academic Defense Strategy for Examiners & Judges

### The 30-Second Defense Answer
> *"Colorectal histopathology requires meticulous examination of tissue architecture and cellular atypia. Standard AI models act as black boxes, predicting tissue classes from pixel representations without interpretable histological evidence. ColonPath-AI V3 integrates established foundation vision models (Phikon-v2) with explicit, verifiable cellular and glandular morphometry (HoVer-Net + U-Net). Our project-specific contributions include a 16-D quantitative morphology descriptor vector, a multimodal late-fusion network (MultimodalFusionNet), multi-source consensus voting, and deterministic anti-hallucination claim validation—delivering evidence-grounded AI decision support and native clinical reports directly on mobile and desktop."*

### Key Technical Defense Questions

#### Q1: "What is your project's specific engineering contribution vs established research?"
**Answer:** *We do not claim to have invented U-Net, HoVer-Net, Phikon-v2, or temperature scaling; those are established, peer-reviewed architectures. Our engineering contribution is the multimodal system integration: formulating the 16-D morphology vector, designing and training MultimodalFusionNet to combine 1024-D visual embeddings with morphological constraints, building the multi-source cross-evidence consensus engine, creating the deterministic EvidenceValidator gatekeeper, and deploying the complete zero-mock pipeline to mobile with native PDF reporting.*

#### Q2: "Why use multimodal late fusion instead of fine-tuning a Vision Transformer?"
**Answer:** *Vision Transformers excel at global texture representation but can miss fine-grained cytological criteria (such as nuclear circularity, nuclear area distribution, and glandular aspect ratios). By explicitly extracting a 16-D morphometric vector through HoVer-Net and U-Net and fusing it with Phikon-v2's 1024-D latent vector in MultimodalFusionNet, our system ensures the final classification is constrained by verifiable biological evidence rather than visual correlations alone.*

#### Q3: "How do you prevent the AI from hallucinating medical advice?"
**Answer:** *We implement a deterministic `EvidenceValidator` gatekeeper. Every generated explanation claim is decomposed into structured parameters and programmatically validated against computed numerical tensors from U-Net, HoVer-Net, and FusionNet before presentation. If any claim contradicts the numerical output, `explanation.validated` is set to false and the error is flagged.*

---

## 6. Citation-Ready Statements for Presentation Slides

- **Dataset Citation:** *"We utilize the NCT-CRC-HE-100K and CRC-VAL-HE-7K benchmarks, containing 107,180 non-overlapping H&E colorectal tissue patches across 9 validated tissue categories [Kather et al., Zenodo:10.5281/zenodo.1214456]."*
- **Gland Method Citation:** *"Gland segmentation utilizes U-Net, an encoder-decoder convolutional architecture with skip connections [Ronneberger et al., MICCAI 2015]."*
- **Nuclear Method Citation:** *"Nuclear analysis utilizes HoVer-Net, leveraging horizontal and vertical distance maps to segment touching nuclei and classify cellular phenotypes [Graham et al., Med Image Anal 2019]."*
- **Foundation Vision Citation:** *"Visual feature representation utilizes Phikon-v2, a ViT-L/16 pathology foundation model pretrained via DINOv2 on 40M+ histopathology tiles [Filiot et al., arXiv 2024; Oquab et al., arXiv 2023]."*
- **Decision-Support Boundary Statement:** *"The system provides AI-assisted quantification and decision support. Final diagnostic determination remains exclusively with a qualified pathologist."*

---
*Document End — ColonPath-AI V3 Technical Defense & Provenance Report*
